3 | Peptide Hydrolases (Proteases)FDA Link
06/2008
-
03/2006 |
3 | Proteins (Proteins, Gene)FDA Link
06/2008
-
03/2006 |
3 | Chelating AgentsIBA
11/2007
-
03/2007 |
3 | Trastuzumab (Herceptin)FDA Link
11/2007
-
03/2007 |
2 | pembrolizumabIBA
01/2020
-
01/2019 |
2 | Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
-
01/2019 |
2 | Dihydrotachysterol (AT 10)IBA
01/2017
-
10/2016 |
2 | Leucine (L-Leucine)FDA Link
11/2012
-
06/2012 |
2 | Phosphotransferases (Kinase)IBA
11/2012
-
06/2012 |
2 | LigandsIBA
02/2010
-
03/2007 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
09/2007
-
03/2007 |
2 | Serine Proteases (Serine Protease)IBA
04/2007
-
03/2006 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 |
1 | Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 |
1 | Cisplatin (Platino)FDA LinkGeneric
01/2022 |
1 | Leucovorin (Folinic Acid)FDA Link
01/2022 |
1 | Fluorouracil (Carac)FDA LinkGeneric
01/2022 |
1 | cyclo(Arg-Pro) (CI 4)IBA
09/2021 |
1 | Hemoglobins (Hemoglobin)IBA
07/2021 |
1 | ibrutinibIBA
07/2021 |
1 | TabletsIBA
07/2021 |
1 | Agammaglobulinaemia Tyrosine KinaseIBA
07/2021 |
1 | Thrombopoietin (c-mpl Ligand)IBA
01/2021 |
1 | romiplostimFDA Link
01/2021 |
1 | Thrombopoietin ReceptorsIBA
01/2021 |
1 | Inosine Triphosphate (ITP)IBA
01/2021 |
1 | eltrombopagFDA Link
01/2021 |
1 | Indicators and Reagents (Reagents)IBA
11/2020 |
1 | Immune Checkpoint InhibitorsIBA
11/2020 |
1 | Blood Proteins (Serum Proteins)IBA
04/2020 |
1 | von Willebrand FactorIBA
04/2020 |
1 | Biomarkers (Surrogate Marker)IBA
01/2020 |
1 | Anticonvulsants (Antiepileptic Drugs)IBA
01/2019 |
1 | B7-H1 AntigenIBA
01/2019 |
1 | MentholFDA Link
12/2018 |
1 | Serum AlbuminIBA
06/2018 |
1 | perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA
05/2018 |
1 | glutathione-bicarbonate-Ringer solution (BSS plus)FDA LinkGeneric
05/2017 |
1 | insulin receptor-related receptor (IRR)IBA
01/2017 |
1 | BilirubinIBA
11/2016 |